Rutgers Cancer Institute

Category

Rutgers Cancer Institute Ramps up COVID-19 Hydroxychloroquine & Zithromax Trial: Following Success from France’s Méditerranée Infection

Rutgers Cancer Institute of New Jersey is participating in a COVID-19 study investigating whether azithromycin (Zithromax) combined with hydroxychloroquine (Plaquenil) is better than hydroxychloroquine alone as a possible treatment for patients diagnosed with...

Rutgers Cancer Institute of New Jersey Secures Grants & Pursues T-Cell Acute Lymphoblastic Leukemia

Rutgers Cancer Institute of New Jersey received over $2 million in grants recently to study potential treatment targets for a rare and aggressive blood cancer called T-cell acute lymphoblastic leukemia (T-ALL). The recent grant awards were reported by Rutgers Cancer...

Pin It on Pinterest